338 abstracts found.



Results filter

Is late diagnosis of cancer real and if so what can we do about it?”

Year:

Session type: ,

Harpal Kumar1

1Cancer Research UK, London, UK


The value of genomics in rare cancers.

Year:

Session type: ,

Ultan McDermott1

1Wellcome Trust Sanger Institute, Hinxton, UK


Probing the transcriptional consequences of Ras and Rho activation

Year:

Session type: ,

Richard Treisman1,2

1Cancer Research UK London Research Institute, London, UK,2Francis Crick Institute, London, UK


Treatment: How should we treat our patients who develop cardiovascular toxicity? How could we have prevented it?

Year:

Session type: ,

Chris Plummer1

1Freeman Hospital, Newcastle upon Tyne, UK




Translating novel diagnostic and therapeutic radiopharmaceuticals into the clinic”

Year:

Session type: ,

Wim Oyen1,2

1The Institute of Cancer Research, London, UK,2The Royal Marsden NHS Foundation Trust, London, UK


Ovarian Cancer screening – update from UK trials

Year:

Session type: ,

Usha Menon1

1University College London, London, England, UK


Therapeutic Implications of DNA repair defects in Metastatic Prostate Cancer

Year:

Session type: ,

Johann de Bono1,2

1The Institute of Cancer Research, London, UK,2Royal Marsden, London, UK




Epigenetic reprogramming in mammalian development

Year:

Session type: ,

Wolf Reik1

1Babraham Institute, Cambridge, UK,2Centre for Trophoblast Research, University of Cambridge, Cambridge, UK,3Wellcome Trust Sanger Institute, Cambridge, UK




Tracking tumour evolution with clonal assays – mutation order matters.

Year:

Session type: ,

David Kent1,2

1Wellcome Trust/ MRC Cambridge Stem Cell Institute, Cambridge, UK,2Department of Haematology University of Cambridge, Cambridge, UK


Progressing radiotherapy-drug combinations towards early phase clinical trials

Year:

Session type: ,

Anthony Chalmers1

1University of Glasgow, Glasgow, UK


Page 27 of 34« First...25...27...Last »